March 26, 2024

Dear Valued Customer,

I am thrilled to announce that Flexan and the broader ILC Dover organization are embarking on a new journey as we join forces with an incredible partner. On behalf of our Board of Directors and the Executive Leadership Team at ILC Dover and Flexan, I am excited to share that Ingersoll Rand, a global provider of mission-critical flow creation and industrial solutions, has entered into an agreement to acquire ILC Dover. The acquisition is subject to customary regulatory approvals and is expected to close in Q2 2024.

Our medical device custom manufacturing business is an essential component of our life sciences business and has rapidly grown over the past several years. By joining Ingersoll Rand, we promise to continue to provide excellent service and elevate our position to offer broader capabilities beyond our current custom contract manufacturing solutions, and best-in-class quality and manufacturing. We are genuinely excited about the opportunities this will generate for you, including additional investment in resources and capabilities in our life sciences segment, further development in product innovation, and added strength and stability from a recognized global partner.

Currently, we do not anticipate any impact to our customers. Your key contacts and relationships, product manufacturing, and business operations will remain unchanged.

I look forward to partnering with Ingersoll Rand, which will unlock valuable new opportunities for Flexan, ILC Dover, and our customers over the long-term. Thank you for the opportunity to continue to serve you and support your mission of developing life-saving medical devices and innovative products in the diverse markets you serve.

If you have any questions, please contact your sales or customer service representative.

Thank you,
Tony Gonzalez
President – Flexan